2025

Publications

Alterations in cardiac function correlate with a disruption in fatty acid metabolism in a mouse model of SMA. Nair NN, Kline RA, Boyd I, Anikumar M, Thomson A, Lamont DJ, Gray GA, Wishart TM, Murray LM.Hum Mol Genet. 2025 Jan 15:ddaf006

Multi-organ kinetic modeling for Na[18F]F pre-clinical total-body PET studies. Benitez-Aurioles J, Clegg PS, Alcaide-Corral CJ, Wimberley C, Tavares AAS.Med Phys. 2025 Feb;52(2):924-937. 

Synthesis and evaluation of 6-arylaminobenzamides as positron emission tomography imaging ligands for the sphingosine-1-phosphate-5 receptor. Morgan TEF, Grant EK, Shaw RC, Waddell LJN, Henry MC, McErlain H, Alcaide-Corral CJ, Pimlott SL, Tavares AAS, Sutherland A.RSC Med Chem. 2025 Jan 3. 

Assessment of a 6-arylaminobenzamide lead derivative as a potential core scaffold for S1P5 positron emission tomography radiotracer development. Shaw RC, Morgan TEF, McErlain H, Alcaide-Corral CJ, Waldman AD, Soloviev D, Lewis DY, Sutherland A, Tavares AAS.Bioorg Med Chem. 2025 Jan 3;119:118057. 

This article was published on